ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2019

Dihydromyricetin Attenuates Metabolic Syndrome And Improves Insulin Sensitivity By Upregulating Insulin Receptor Substrate-1 (Y612) Tyrosine Phosphorylation In db/db Mice.

Jidong He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.